Follow
Abel Armando Arredondo Lopez
Abel Armando Arredondo Lopez
Investigador en Ciencias Médicas F, INSP. Investigador Nacional, SNI.
Verified email at insp.mx
Title
Cited by
Cited by
Year
Economía y salud
J Frenk, R Lozano, MA González-Block
México, DF: Fundación Mexicana para la Salud, 1994
313*1994
Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy
S Barquera, I Campos-Nonato, C Aguilar-Salinas, R Lopez-Ridaura, ...
Globalization and health 9 (1), 3, 2013
2752013
Economic consequences of epidemiological changes in diabetes in middle-income countries the Mexican case
A Arredondo, A Zúñiga
Diabetes Care 27 (1), 104-109, 2004
2202004
Análisis y reflexión sobre modelos teóricos del proceso salud-enfermedad
A Arredondo
Cad Saúde Pública 8 (3), 254-81, 1992
2181992
Costos de la diabetes en Ameŕica latina: evidencias del caso mexicano
A Arredondo, E De Icaza
Value in health 14 (5), S85-S88, 2011
2022011
Modelos explicativos sobre la utilización de servicios de salud: revisión y análisis
A Arredondo, V Meléndez
Salud pública de México 34 (1), 36-49, 1992
1691992
Modelos conceptuales y paradigmas en salud pública
C Hernández-Girón, E Orozco-Núñez, A Arredondo-López
Revista de salud pública 14 (2), 315-324, 2012
1042012
Road traffic injuries in an urban area in Mexico: An epidemiological and cost analysis
M Hı́jar, A Arredondo, C Carrillo, L Solórzano
Accident Analysis & Prevention 36 (1), 37-42, 2004
1032004
The cost of diabetes in Latin America and the Caribbean in 2015: evidence for decision and policy makers
A Barcelo, A Arredondo, A Gordillo–Tobar, J Segovia, A Qiang
Journal of global health 7 (2), 2017
922017
Health disparities from economic burden of diabetes in middle-income countries: evidence from México
A Arredondo, G Reyes
PloS one 8 (7), e68443, 2013
832013
Prescripción, acceso y gasto en medicamentos entre usuarios de servicios de salud en México
R Leyva-Flores, J Erviti-Erice, M de la Luz Kageyama-Escobar, ...
Salud pública de México 40 (1), 24-31, 1998
721998
Costo-efectividad de intervenciones para insuficiencia renal crónica terminal
A Arredondo, R Rangel, E de Icaza
Revista de Saúde Pública 32 (6), 556-565, 1998
711998
Costos económicos en la producción de servicios de salud: del costo de los insumos al costo de manejo de caso
A Arredondo, T Damián
Salud pública de México 39 (2), 117-124, 1997
671997
Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America
A Arredondo, A Azar, AL Recamán
Global public health 13 (7), 780-787, 2018
662018
Epidemiologic Changes and Economic Burden of Hypertension in Latin America Evidence from Mexico
A Arredondo, A Zúñiga
American journal of Hypertension 19 (6), 553-559, 2006
632006
Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico
A Arredondo, A Zuñiga, I Parada
Public Health 119 (8), 711-720, 2005
622005
Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems
A Arredondo, R Aviles
PloS one 10 (3), e0118611, 2015
612015
Determinants of performance of health systems concerning maternal and child health: A global approach
CE Pinzón-Flórez, JA Fernández-Niño, M Ruiz-Rodríguez, ÁJ Idrovo, ...
PloS one 10 (3), e0120747, 2015
562015
Equity, governance and financing after health care reform: lessons from Mexico
A Arredondo, E Orozco
The International journal of health planning and management 23 (1), 37-49, 2008
56*2008
Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine
A Arredondo
BMC medicine 12 (1), 1, 2014
552014
The system can't perform the operation now. Try again later.
Articles 1–20